Mallo F, Alvarez C V, Benitez L, Burguera B, Coya R, Casanueva F F, Dieguez C
Department of Fundamental Biology, Faculty of Sciences, University of Vigo, Spain.
Neuroendocrinology. 1993;57(2):247-56. doi: 10.1159/000126366.
His-dTrp-Ala-Trp-dPhe,Lys-NH2(GHRP-6) is a synthetic compound that releases GH in a dose-response and specific manner in several species and that may well be related to an endogenous compound of similar structure. The aim of this study was to investigate the in vivo GH responses to GHRP-6 in pentobarbital anesthetized rats. Specifically and in order to avoid the influence of endogenous GHRH and somatostatin secretion we studied the GH responses to GHRP-6 in animals with surgical ablation of the hypothalamus, confirmed by histological assessment, as well as in hypophysectomyzed-transplanted rats bearing two hypophyses under the renal capsule. Since it has been previously reported that rats pretreated with GHRH (10 micrograms/kg i.p. every 12 h for 15 days) rather than saline-treated rats have greater GH responses to acutely administered GHRH, we compared the self-potentiating effect of chronic GH pretreatment with GHRP-6 (10 micrograms/kg i.p. every 12 h). Furthermore we also studied the influence of estrogens, glucocorticoids, free fatty acids (FFA) and bombesin on somatotroph responsiveness to GHRP-6 in intact rats. We found a greater GH response to GHRP-6 in rats that underwent a surgical ablation of the hypothalamus 36 h prior to the test than in sham-operated rats. A direct stimulatory effect of GHRP-6 on in vivo GH secretion was demonstrated by a clear GH response to GHRP-6 in hypophysectomyzed-transplanted rats. In addition, we found a similar response whether the animals were pretreated with GHRH or GHRP-6 over the previous 2 weeks. Finally, we found that both estrogen- and testosterone-treated rats have greater GH responses to GHRP-6 than untreated rats. On the other hand, chronic dexamethasone administration, acute elevation of circulating FFA levels and bombesin administration markedly inhibited GH responses to GHRP-6. In contrast to the effects exerted on GH responses to GHRP-6 estrogen administration led to a decrease in GH responses to GHRH while dexamethasone did not affect the GH responses to GHRH, highlighting a differential regulation of these hormones on somatotroph responsiveness to these peptides.
组氨酸-色氨酸-丙氨酸-色氨酸-对氟苯丙氨酸,赖氨酸-氨基(GHRP - 6)是一种合成化合物,它能在多种物种中以剂量反应和特异性方式释放生长激素(GH),并且很可能与一种结构相似的内源性化合物有关。本研究的目的是调查戊巴比妥麻醉大鼠体内对GHRP - 6的GH反应。具体而言,为了避免内源性生长激素释放激素(GHRH)和生长抑素分泌的影响,我们研究了经组织学评估证实下丘脑手术切除的动物以及肾被膜下植入两个垂体的垂体切除移植大鼠对GHRP - 6的GH反应。由于先前有报道称,预先用GHRH(10微克/千克腹腔注射,每12小时一次,共15天)处理的大鼠比生理盐水处理的大鼠对急性给予的GHRH有更大的GH反应,我们比较了用GHRP - 6(10微克/千克腹腔注射,每12小时一次)进行慢性GH预处理的自身增强作用。此外,我们还研究了雌激素、糖皮质激素、游离脂肪酸(FFA)和蛙皮素对完整大鼠中生长激素细胞对GHRP - 6反应性的影响。我们发现,在测试前36小时接受下丘脑手术切除的大鼠对GHRP - 6的GH反应比假手术大鼠更大。垂体切除移植大鼠对GHRP - 6有明显的GH反应,证明了GHRP - 6对体内GH分泌的直接刺激作用。此外,我们发现,无论动物在之前2周是用GHRH还是GHRP - 6预处理,反应都相似。最后,我们发现雌激素和睾酮处理的大鼠对GHRP - 6的GH反应都比未处理的大鼠更大。另一方面,慢性地塞米松给药、循环FFA水平的急性升高和蛙皮素给药均显著抑制了对GHRP - 6的GH反应。与对GHRP - 6的GH反应所产生的影响相反,雌激素给药导致对GHRH的GH反应降低,而地塞米松不影响对GHRH的GH反应,突出了这些激素对生长激素细胞对这些肽反应性的差异调节。